S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
NYSE:NVST

Envista (NVST) Stock Forecast, Price & News

$27.60
-0.28 (-1.00%)
(As of 11:39 AM ET)
Compare
Today's Range
$27.41
$27.86
50-Day Range
$27.56
$35.70
52-Week Range
$27.25
$43.29
Volume
463,635 shs
Average Volume
2.01 million shs
Market Capitalization
$4.52 billion
P/E Ratio
22.44
Dividend Yield
N/A
Price Target
$45.50

Envista MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
64.7% Upside
$45.50 Price Target
Short Interest
Healthy
3.58% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.62
Upright™ Environmental Score
News Sentiment
0.81mentions of Envista in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.90%
From $1.86 to $2.10 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

165th out of 969 stocks

Dental Equipment & Supplies Industry

2nd out of 5 stocks


NVST stock logo

About Envista (NYSE:NVST) Stock

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Price History

NVST Stock News Headlines

Here’s Why Envista Holdings Corp. (NVST) Declined in Q2
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Envista (NYSE: NVST)
NVST - Envista Holdings Corporation
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Envista: Q2 Earnings Snapshot
Envista Reports Second Quarter 2023 Earnings
Envista (NVST) Beats Q2 Earnings and Revenue Estimates
Envista Schedules Second Quarter 2023 Earnings Call
Envista Reports First Quarter 2023 Earnings
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

NVST Company Calendar

Last Earnings
8/02/2023
Today
10/02/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Employees
12,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$45.50
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+63.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$243.10 million
Pretax Margin
10.20%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$3.14 per share
Book Value
$25.80 per share

Miscellaneous

Free Float
161,858,000
Market Cap
$4.57 billion
Optionable
Optionable
Beta
1.42
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Amir AghdaeiMr. Amir Aghdaei (Age 64)
    Pres, CEO & Director
    Comp: $3.42M
  • Mr. Howard H. YuMr. Howard H. Yu (Age 51)
    Sr. VP & CFO
    Comp: $842.14k
  • Mr. Mark E. NanceMr. Mark E. Nance (Age 54)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $753.64k
  • Mr. Patrik Eriksson (Age 55)
    Sr. VP & Pres of Nobel Biocare
    Comp: $834.61k
  • Mr. Stephen Keller (Age 49)
    VP of Investor Relations
  • Juan Arbona
    Chief Compliance Officer
  • Mr. Mischa M. ReisMr. Mischa M. Reis (Age 50)
    Sr. VP of Strategy & Corp. Devel.
  • Mr. Filippo Impieri
    Sr. VP of Emerging Markets
  • Ms. Claudia Ortiz
    Sr. VP of Regulatory Affairs & Quality Assurance
  • Mr. Eric Conley (Age 48)
    Sr. VP & Pres of Orthodontics













NVST Stock - Frequently Asked Questions

Should I buy or sell Envista stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NVST shares.
View NVST analyst ratings
or view top-rated stocks.

What is Envista's stock price forecast for 2023?

4 Wall Street analysts have issued 1-year target prices for Envista's stock. Their NVST share price forecasts range from $43.00 to $48.00. On average, they expect the company's share price to reach $45.50 in the next year. This suggests a possible upside of 63.2% from the stock's current price.
View analysts price targets for NVST
or view top-rated stocks among Wall Street analysts.

How have NVST shares performed in 2023?

Envista's stock was trading at $33.67 at the beginning of 2023. Since then, NVST stock has decreased by 17.2% and is now trading at $27.88.
View the best growth stocks for 2023 here
.

Are investors shorting Envista?

Envista saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,860,000 shares, an increase of 21.1% from the August 31st total of 4,840,000 shares. Based on an average trading volume of 1,990,000 shares, the days-to-cover ratio is presently 2.9 days.
View Envista's Short Interest
.

When is Envista's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our NVST earnings forecast
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) released its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.02. The firm had revenue of $662.40 million for the quarter, compared to analyst estimates of $655.81 million. Envista had a trailing twelve-month return on equity of 7.60% and a net margin of 8.40%. The firm's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.48 earnings per share.

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

(NVST) raised $603 million in an IPO on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

What is Envista's stock symbol?

Envista trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVST."

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Envista's stock price today?

One share of NVST stock can currently be purchased for approximately $27.88.

How much money does Envista make?

Envista (NYSE:NVST) has a market capitalization of $4.57 billion and generates $2.57 billion in revenue each year. The company earns $243.10 million in net income (profit) each year or $1.23 on an earnings per share basis.

How many employees does Envista have?

The company employs 12,700 workers across the globe.

How can I contact Envista?

Envista's mailing address is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. The official website for the company is www.envistaco.com. The company can be reached via phone at 714-817-7000, via email at ir@envistaco.com, or via fax at 714-817-5450.

This page (NYSE:NVST) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -